Request Demo
Last update 20 May 2026
ART-104 (Arnatar)
Last update 20 May 2026
Overview
Basic Info
Drug Type ASO |
Synonyms Alagille Syndrome Treatment (Arnatar), ART104 |
Target |
Action modulators |
Mechanism Protein jagged-1 modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseEarly Phase 1 |
First Approval Date- |
RegulationOrphan Drug (United States), Rare Pediatric Disease (United States) |
Login to view timeline
Structure/Sequence
Boost your research with our RNA technology data.
login
or
Related
1
Clinical Trials associated with ART-104 (Arnatar)ChiCTR2500106605
An Exploratory Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of Subcutaneous ART-104 Injection in Patients with Alagille Syndrome due to JAG1 Gene Mutation
100 Clinical Results associated with ART-104 (Arnatar)
Login to view more data
100 Translational Medicine associated with ART-104 (Arnatar)
Login to view more data
100 Patents (Medical) associated with ART-104 (Arnatar)
Login to view more data
100 Deals associated with ART-104 (Arnatar)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Alagille Syndrome | Phase 1 | China | 28 Jul 2025 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free